Fortrea Holdings shares rise 1.93% premarket after announcing natural history research reducing placebo use in oncology trials.

viernes, 8 de agosto de 2025, 9:14 am ET1 min de lectura
FTRE--
Fortrea Holdings Inc. rose 1.93% in premarket trading, with the company's recent news highlighting advancements in natural history research and the use of synthetic control arms in oncology trials. This development is expected to reduce placebo use, help more patients access potential life-saving drugs, and accelerate trial processes, leading to faster time to market.

Fortrea Holdings shares rise 1.93% premarket after announcing natural history research reducing placebo use in oncology trials.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios